
Megmavert 16mg Tablet
Marketer
Ridhima Biocare
Salt Composition
Betahistine (16mg)
Overview Megmavert 16mg Tablet
Inner ear disorder Ménière's disease, characterized by vertigo, tinnitus, and hearing loss (potentially from inner ear fluid buildup), is treated and prevented using 16mg VertiGone tablets. These tablets lessen fluid accumulation, thus alleviating symptoms. For optimal results, swallow VertiGone whole with water, consistently at the same time(s) daily, as directed by your physician. Treatment may extend for months; continue as prescribed, even with symptom improvement. Common side effects are headache, nausea, and dyspepsia; abdominal pain and bloating may also occur. Food may mitigate gastrointestinal discomfort. Consult your doctor prior to use if you have a peptic ulcer, asthma, or hypertension/hypotension. Disclose all other medications for safety. Inform your physician if pregnant, planning pregnancy, or breastfeeding.
Primary Ingredients of Megmavert 16mg Tablet
No information provided. Unable to rewrite.
Uses of Megmavert 16mg Tablet
Managing Meniere's disease
Major Benefits of Megmavert 16mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Megmavert 16mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Megmavert 16mg Tablet:
- Headache
- Indigestion
- Nausea
- Stomach pain
- Bloating
How to use Megmavert 16mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Megmavert 16mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Megmavert 16mg Tablet works:
Histametic analog Megmavert 16mg tablets enhance inner ear circulation, thereby lessening fluid pressure. This excess fluid pressure triggers nausea, vertigo, and dizziness—characteristic symptoms of Ménière's disease. The tablets also attenuate nerve impulses from the inner ear to the brain, providing Ménière's disease symptom relief.
SAFETY ADVICE
AlcoholSAFE
Megmavert 16mg Tablet's concurrent use with alcohol presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
The use of Megmavert 16mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Megmavert 16mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Megmavert 16mg Tablets.
KidneySAFE IF PRESCRIBED
Use of the 16mg Megmavert tablet in patients with kidney disease is likely safe. Existing evidence indicates dose modification may not be necessary, but physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding Megmavert 16mg Tablet use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Megmavert 16mg Tablet :
Omit any missed Megmavert 16mg Tablet dose and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Megmavert 16mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Histamine Derivative |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Actions | Meniere's Disease and Histamine Analogs |
